CD

Chris Derespino

Chief Business Officer

3T Biosciences

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
3T Biosciences
Industry
research
Employees
30.0
Seniority
C suite
Annual Revenue
2000000.0
Total Funding
52000000.0
Latest Funding
Series A

Technologies

Cloudflare DNS SendInBlue Gmail Outlook Google Apps Microsoft Office 365 CloudFlare Hosting DigitalOcean Google Tag Manager Google Font API Gravity Forms Mobile Friendly WordPress.org Google Analytics Remote

Keywords

biotechnology research immunotherapy t cell receptor cancer treatment target discovery therapeutic development solid tumors immune-mediated diseases machine learning 3t-trace platform patient immune responses novel targets tcr specificity tcr mimetics safer therapies effective treatments tumor-specific biotherapeutics cancer immunotherapy patient biomarkers therapeutic optimization data-driven approaches synthetic biology computational biology high-throughput screening high-diversity target libraries cross-reactivity validation toxicology screening investor partnering biopharmaceutical collaborations translational science clinical research data science bioinformatics algorithm development patient populations autoimmune diseases viral infections therapeutic modalities peptide vaccines tcr bispecifics precision medicine innovation culture patient-centric therapies pharmaceutical r&d scientific expertise artificial intelligence information technology & services biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans